EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 6 March 2025

News

A Call for Effective Stakeholder Engagement and Capacity Building during the Implementation...
05 March 2025

39 representatives of the EU health community welcome the publication of the EHDS in the Official Journal of the EU.... Read more

EFPIA seeks clarity on Urban Wastewater Treatment Directive in the European Courts
03 March 2025

Europe needs environmental legislation that works, where all sectors are incentivised to sustainably reduce micro-pollutants... Read more

Blogs

Cancer care 2030: from policy ambition to impact (Guest blog)
05 March 2025

Why is it important to continue the Europe's Beating Cancer Plan? Read more

World Obesity Day: a chronic disease demands urgent action
04 March 2025

Scientific understanding and clinical management of obesity have evolved, but attitudes, policies and societal narratives... Read more

IMAGINE a healthier, more competitive Europe: Interview with Monica Shaw

In this short video, Monica Shaw, SVP, Commercial Head Cell Therapy at BMS, shares her perspective on the urgent need for policies that support investment in R&D, strengthen Europe’s competitiveness, and ensure faster, more equitable access to medicines for patients.

Watch here to hear her insights on the path to a healthier future for Europe.

Events

Cancer Care 2030: From policy ambition to impact
19 March 2025 (Brussels, Belgium)

Join us on 19 March in Brussels to discuss how we can work together to accelerate progress to improve cancer care Read more

Unlocking efficiency through reliance: Navigating the EMA post-authorization framework
03 April 2025 (Virtual event)

Register now to join this webinar. Read more

2024 Pipeline: Obesity

Imagine if weight-loss treatments could lower the risk of diabetes, cardiovascular disease and stroke, helping people to live healthier lives.

Discover more in our pipeline review.

What we are reading

Europe is losing clinical trials to China, while a key legislative proposal has now been postponed...
On 05 March 2025 (Dagens Pharma)

The newly appointed EU Commission acknowledges that the legislation for clinical trials, which was updated a few... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu